[Cognitive disorders in Parkinson's disease without dementia]
1Inserm U 610 et Fédération de neurologie, Hôpital de la Salpêtrière, Paris. richard.levy@psl.aphp.fr
Psychologie & Neuropsychiatrie Du Vieillissement
|May 2, 2013
Summary
Cognitive disorders in Parkinson's disease stem from attentional deficits, primarily linked to striatal dopamine depletion. These issues impact memory and planning, worsening with disease progression.
Area of Science:
- Neuroscience
- Cognitive Neurology
- Movement Disorders
Context:
- Parkinson's disease (PD) frequently presents with subtle cognitive impairments in non-demented patients.
- These deficits often manifest as difficulties in controlling attentional resources, impacting executive functions.
Purpose:
- To elucidate the neurobiological underpinnings of cognitive disorders in early Parkinson's disease.
- To differentiate the roles of striatal dopamine depletion versus other neurotransmitter system involvements in PD-related cognitive decline.
Summary:
- Cognitive deficits in non-demented Parkinson's patients are primarily associated with impaired attentional control, affecting planning, memory encoding, and retrieval.
- Early cognitive symptoms are strongly linked to striatal dopamine depletion, particularly in the caudate nuclei, leading to basal ganglia dysfunction and prefrontal impairment.
- Later stages may involve cholinergic, serotoninergic, and noradrenergic pathway disruptions, and potentially cortical lesions, further modifying cognitive deficits.
Impact:
- Understanding these early cognitive changes is crucial for timely diagnosis and intervention in Parkinson's disease.
- This research highlights the critical role of the dopaminergic system in cognitive functions affected by Parkinson's disease.
- Differentiates early-stage cognitive profiles from those in later disease progression, informing targeted therapeutic strategies.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.